Related Experiment Video
Updated: Dec 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Consensus-based recommendations for the management of juvenile systemic sclerosis
Ivan Foeldvari1, Roberta Culpo2, Francesca Sperotto2
1Hamburger Zentrum für Kinder- und Jugendrheumatologie, Schoen Clinic, Hamburg-Eilbek, Germany.
Insights
Juvenile systemic sclerosis (JSSc) lacks international treatment guidelines. This initiative offers expert-driven recommendations for JSSc assessment and treatment to improve pediatric patient outcomes.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Rare Childhood Conditions
Background:
- Juvenile systemic sclerosis (JSSc) is a rare pediatric autoimmune disease.
- Lack of international consensus on JSSc assessment and treatment hinders optimal patient care.
- Early recognition and management of internal organ involvement are crucial for long-term outcomes.
Purpose of the Study:
- To establish expert-driven recommendations for the assessment and treatment of JSSc.
- To improve the long-term outcomes for children diagnosed with JSSc.
- To standardize care for JSSc across Europe.
Main Methods:
- A European expert initiative (SHARE) synthesized best available evidence and expert opinion.
- Recommendations cover skin assessment and early detection of internal organ involvement.
- A proposed disease severity score for structured outcome assessment.
Main Results:
- Developed recommendations for comprehensive JSSc assessment, including internal organ monitoring.
- Proposed a stepwise treatment approach to standardize care.
- Introduced a disease severity score for outcome evaluation, requiring further validation.
Conclusions:
- The SHARE initiative provides crucial recommendations to unify JSSc care standards in Europe.
- Implementing these guidelines aims to reduce morbidity and mortality in pediatric patients with JSSc.
- Further validation of the proposed severity score in a larger patient cohort is recommended.
Abstract:
Juvenile systemic sclerosis (JSSc) is a rare disease of childhood and currently no international consensus exists with regard to its assessment and treatment. This SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) initiative, based on expert opinion informed by the best available evidence, provides recommendations for the assessment and treatment of patients with JSSc with a view to improving their outcome. Experts focused attention not only on the skin assessment but also on the early signs of internal organ involvement whose proper treatment can significantly affect the long-term outcome. A score for disease severity is proposed in order to perform a structured assessment of outcome over time but a validation in a wider patient population is recommended. Finally, a stepwise treatment approach is proposed in order to unify the standard of care throughout Europe with the aim to reduce morbidity and mortality in this disease.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Cystic Fibrosis: Management
Sinus disease and chronic...
Myocarditis III: Medical Management
Atherosclerosis III: Management
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease IV: Nursing Management
